Cancers 2010, 2(3), 1513-1527; doi:10.3390/cancers2031513
Review

Neural Invasion in Pancreatic Cancer: The Past, Present and Future

email, email, email, email, email and * email
Received: 2 June 2010; in revised form: 30 June 2010 / Accepted: 7 July 2010 / Published: 14 July 2010
(This article belongs to the Special Issue Pancreatic Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: In the past 15 years, invasion of nerves by cancer cells has escaped from its role as a mere bystander in cancer biology and turned into an attractive niche to study the heterotypic interaction between cancer cells and neurons. Today, neural invasion (NI) in pancreatic cancer (PCa) stands out due to the recent demonstration of its association with tumor progression, local recurrence and neuropathic pain. Accordingly, recent research on NI in PCa revealed the critical involvement of numerous nerve- or cancer cell-derived molecules in several novel in vitro and in vivo models of NI, which, however, still need further major improvement.
Keywords: neural invasion; neurotrophic factors; pancreatic neuropathy; neuroplasticity; neurotropism
PDF Full-text Download PDF Full-Text [619 KB, uploaded 14 July 2010 14:44 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Demir, I.E.; Ceyhan, G.O.; Liebl, F.; D’Haese, J.G.; Maak, M.; Friess, H. Neural Invasion in Pancreatic Cancer: The Past, Present and Future. Cancers 2010, 2, 1513-1527.

AMA Style

Demir IE, Ceyhan GO, Liebl F, D’Haese JG, Maak M, Friess H. Neural Invasion in Pancreatic Cancer: The Past, Present and Future. Cancers. 2010; 2(3):1513-1527.

Chicago/Turabian Style

Demir, Ihsan Ekin; Ceyhan, Güralp O.; Liebl, Florian; D’Haese, Jan G.; Maak, Matthias; Friess, Helmut. 2010. "Neural Invasion in Pancreatic Cancer: The Past, Present and Future." Cancers 2, no. 3: 1513-1527.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert